Les effets des solutions colloïdes sur ľhémostase

[1]  G. Hempelmann,et al.  Influence of different volume therapies on platelet function in the critically ill , 1996, Intensive Care Medicine.

[2]  S. Kozek-Langenecker,et al.  The Effects of High Molecular Weight Hydroxyethyl Starch Solutions on Platelets , 2004, Anesthesia and analgesia.

[3]  D. Schmartz,et al.  3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[4]  F. Bepperling,et al.  Volume Efficacy and Reduced Influence on Measures of Coagulation Using Hydroxyethyl Starch 130/0.4 (6%) with an Optimised in Vivo Molecular Weight in Orthopaedic Surgery , 2004, Drugs in R&D.

[5]  E. Macintyre,et al.  The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander , 2004, Intensive Care Medicine.

[6]  K. Reinhart,et al.  Equivalence of hydroxyethyl starch HES 130/0. 4 and HES 200/0. 5 for perioperative volume replacement in major gynaecological surgery , 2003, Acta anaesthesiologica Scandinavica.

[7]  H. Kress,et al.  Binding of Hydroxyethyl Starch Molecules to the Platelet Surface , 2003, Anesthesia and analgesia.

[8]  C. Mélot,et al.  Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. , 2003, British journal of anaesthesia.

[9]  C. Geisen,et al.  Large-dose Hydroxyethyl Starch 130/0.4 Does Not Increase Blood Loss and Transfusion Requirements in Coronary Artery Bypass Surgery Compared with Hydroxyethyl Starch 200/0.5 at Recommended Doses , 2003, Anesthesiology.

[10]  D. Spahn,et al.  Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury , 2003, Anesthesia and analgesia.

[11]  Stephanie B. Jones,et al.  The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. , 2003, Anesthesia and analgesia.

[12]  Brigitte Ickx,et al.  Interactions entre les solutés colloïdes et l'hémostase , 2002 .

[13]  J. Boldt,et al.  Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. , 2002, British journal of anaesthesia.

[14]  W. Schobersberger,et al.  The Effects of Perioperatively Administered Colloids and Crystalloids on Primary Platelet-Mediated Hemostasis and Clot Formation , 2002, Anesthesia and analgesia.

[15]  R. Hahn,et al.  Hemostasis in patients of different ABO blood groups. , 2002, Anesthesia and Analgesia.

[16]  W. Schobersberger,et al.  The Effect of the Combined Administration of Colloids and Lactated Ringer’s Solution on the Coagulation System: An In Vitro Study Using Thrombelastograph® Coagulation Analysis (ROTEG®) , 2002, Anesthesia and analgesia.

[17]  T. Ruttmann.  Editorial II Haemodilution enhances coagulation , 2002 .

[18]  K. Ng,et al.  In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. , 2002, British journal of anaesthesia.

[19]  R. Strauss,et al.  A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch , 2002, Transfusion.

[20]  B. Lisander,et al.  Blood loss in prosthetic hip replacement is not influenced by the AB0 blood group. , 2001, The European journal of surgery = Acta chirurgica.

[21]  B. Gustorff,et al.  The Effects of Hydroxyethyl Starches of Varying Molecular Weights on Platelet Function , 2001, Anesthesia and analgesia.

[22]  E. de Jonge,et al.  Effects of different plasma substitutes on blood coagulation: A comparative review , 2001, Critical care medicine.

[23]  C. Samama,et al.  Hemostatic Changes in Patients Receiving Hydroxyethyl Starch: The Influence of ABO Blood Group , 2001, Anesthesia and analgesia.

[24]  P. Coriat,et al.  Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5 , 2001, Anesthesia and analgesia.

[25]  J. Boldt,et al.  The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. , 2001, Anesthesia and analgesia.

[26]  C. Samama.  Thromboelastography: the next step. , 2001, Anesthesia and analgesia.

[27]  C. Colwell,et al.  Prevention of venous thromboembolism. , 1994, Chest.

[28]  W. van Oeveren,et al.  A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[29]  H. Willschke,et al.  The Effect of Hydroxyethyl Starch 200 kD on Platelet Function , 2000, Anesthesia and analgesia.

[30]  J. Boldt.  Volume replacement in the surgical patient--does the type of solution make a difference? , 2000, British journal of anaesthesia.

[31]  C. Konrad,et al.  In Vitro Effects of Different Medium Molecular Hydroxyethyl Starch Solutions and Lactated Ringer’s Solution on Coagulation Using SONOCLOT , 2000, Anesthesia and analgesia.

[32]  M. Khaleq,et al.  Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement. , 1999, Clinical biochemistry.

[33]  P. Glass,et al.  Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. , 1999, Anesthesia and analgesia.

[34]  W. Schobersberger,et al.  Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery. , 1999, British journal of anaesthesia.

[35]  C. Konrad,et al.  The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer's solution on markers of coagulation: an analysis using SONOCLOT. , 1999, Anesthesia and analgesia.

[36]  R. Strauss,et al.  An international view of hydroxyethyl starches , 1999, Intensive Care Medicine.

[37]  U. Bothner,et al.  Peri‐operative tolerance to large‐dose 6% HES 200/0.5 in major urological procedures compared with 5% human albumin , 1999, Anaesthesia.

[38]  D. Cox,et al.  Thrombelastogram reveals hypercoagulability after administration of gelatin solution. , 1999, British journal of anaesthesia.

[39]  D. Cook,et al.  Crystalloids vs. colloids in fluid resuscitation: a systematic review. , 1999, Critical care medicine.

[40]  A. Kuitunen,et al.  Hydroxyethyl starch impairs in vitro coagulation , 1998, Acta anaesthesiologica Scandinavica.

[41]  S. Heptinstall,et al.  Effects of gelatin-based resuscitation fluids on platelet aggregation. , 1998, British journal of anaesthesia.

[42]  M. James,et al.  In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. , 1998, British journal of anaesthesia.

[43]  R. Ibbotson,et al.  Reduced quality of clot formation with gelatin-based plasma substitutes. , 1998, British journal of anaesthesia.

[44]  D. Prough,et al.  Hypertonic saline dextran: efficacy and regulatory approval , 1998, Acta anaesthesiologica Scandinavica.

[45]  J. Treib,et al.  Hydroxyéthylamidons: effets sur l'hémostase , 1998 .

[46]  J. Waitzinger,et al.  Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers , 1998, Clinical drug investigation.

[47]  E. Mortier,et al.  In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography , 1997, Anaesthesia.

[48]  B. Seifert,et al.  Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. , 1997, British journal of anaesthesia.

[49]  W. van Oeveren,et al.  Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[50]  M. Durieux,et al.  Hydroxyethyl Starch: Safe or Not , 1997, Anesthesia and analgesia.

[51]  S. Reeves,et al.  The Effects of Desmopressin and 6% Hydroxyethyl Starch on Factor VIII: C , 1996, Anesthesia and analgesia.

[52]  K. Lindner,et al.  Large-Dose Administration of 6% Hydroxyethyl Starch 200/0.5 for Total Hip Arthroplasty: Plasma Homeostasis, Hemostasis, and Renal Function Compared to Use of 5% Human Albumin , 1996, Anesthesia and analgesia.

[53]  K. Schimrigk,et al.  Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration. , 1996, Haemostasis.

[54]  K. Schimrigk,et al.  All medium starches are not the same: Influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation , 1996, Transfusion.

[55]  M. James,et al.  Haemodilution induces a hypercoagulable state. , 1996, British journal of anaesthesia.

[56]  L. Mortelmans,et al.  Effects of 6% Hydroxyethyl Starch and 3% Modified Fluid Gelatin on Intravascular Volume and Coagulation During Intraoperative Hemodilution , 1995, Anesthesia and analgesia.

[57]  M. Eriksson,et al.  Effect of dextran on plasma tissue plasminogen activator (t‐PA) and plasminogen activator inhibitor‐1(PAI‐1) during surgery , 1995, Acta anaesthesiologica Scandinavica.

[58]  H. Eichler,et al.  Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: Comparison with albumin , 1994, Critical care medicine.

[59]  J. Vermylen,et al.  Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. , 1992, Anesthesia and analgesia.

[60]  G. Hempelmann,et al.  Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. , 1992, Anesthesia and analgesia.

[61]  D. Galanakis.  Anticoagulant Albumin Fragments That Bind to Fibrinogen/Fibrin: Possible Implications , 1992, Seminars in thrombosis and hemostasis.

[62]  J. Svensson,et al.  Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers. , 1991, Thrombosis research.

[63]  W. Marks,et al.  The effect of ABO blood group on the diagnosis of von Willebrand disease. , 1987, Blood.

[64]  J. Batlle,et al.  Effect of Dextran on Factor Vlll/von Willebrand Factor Structure and Function , 1985, Thrombosis and Haemostasis.

[65]  R. Strauss,et al.  Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII , 1985, Transfusion.

[66]  D. Bergqvist.  Dextran and haemostasis. A review. , 1982, Acta chirurgica Scandinavica.